Jonathan Hasselmann
1Patents
0h-index
6Co-inventors
19Inventor score
Filing activity: Dec 21, 2022 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12421517B2 | Genetic modification of mammalian cells to confer resistance to CSF1R antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.